SK Life Science, Inc.

SK Biopharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for Cenobamate

Application seeks indication for primary generalized tonic-clonic (PGTC) seizures and expansion of existing focal-onset seizure indication to…